Tag: TP53 mutation

Prostate cancer risk stratification by histological grade and genetic markers
Clinical UpdatesExplainersPerspectivesPractice

What makes prostate cancer aggressive? Biology, genetics, and clinical grading explained

Prostate cancer aggressiveness is determined by histological grade (Gleason score), genetic mutations (PTEN loss, TP53, BRCA2), and clinical progression patterns.…

By
GMJ Practice Desk

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →